News | May 03, 2025
RPG Life Sciences posts Q4 FY25 net profit at Rs. 117.35 Cr
RPG Life Sciences has reported total income of Rs. 148.15 crores during the period ended March 31, 2025
RPG Life Sciences has reported total income of Rs. 148.15 crores during the period ended March 31, 2025
Vimta Labs has reported total income of Rs. 96.08 crores during the period ended March 31, 2025
The company has posted net profit of Rs. 406.7 crores for the Financial Year ended March 31, 2025
The company has reported total income of Rs. 628.4 crores during the period ended March 31, 2025
The company delivered revenues of Rs. 5,554 crore, representing 10% growth in FY25
Syngene reported revenue growth of 11% year-on-year, and 8% sequentially crossing the Rs. 1,000 Cr in a quarter threshold for the first time
For the financial year ended March 31, 2025, Thyrocare has reported total income of Rs.702.18 crores
Findings likely to generate hypotheses about potential new uses of drugs
Revenue from operations also dropped 8.3 per cent at Rs. 133.5 crore in Q3 FY25
Glenmark’s consolidated revenue was at Rs. 3,387.6 crore as against Rs. 2,506.7 crore recording an increase of 35.1% YoY
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
